GlassScriptPhysician profile
Tosha Rogers-Jones
NPI 1649473497
$45,801.49
in general payments reported to CMS, 2019-2025
10 companies · $44K in 2025
The $44K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2020: $34.32 · 2021: $663 · 2022: $533 · 2023: $457 · 2024: $251 · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Travel and Lodging: $7,335 · Food and Beverage: $1,959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,100.00 |
| Travel and Lodging | $7,335.41 |
| Food and Beverage | $1,959.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $44,239.48 | 2022-2025 | Apretude |
| Theratechnologies INC. | $650.00 | 2021 | |
| Novo Nordisk INC | $445.73 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Gilead Sciences, INC. | $207.36 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $89.78 | 2022-2023 | |
| Acessa Health INC. | $69.16 | 2019 | |
| Shield Therapeutics INC | $37.77 | 2022 | |
| Avion Pharmaceuticals | $22.83 | 2019 | |
| Abbvie INC. | $21.72 | 2022 | |
| Allergan, INC. | $17.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tosha Rogers-Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.